RxSight Reports Third-Quarter Revenue of $24.6 Million, Net Loss of $16.2 Million
Third-quarter 2026 revenue fell 19% from $30.3 million a year earlier. Net loss was $16.2 million, or $0.39 per diluted share, compared with $9.8 million, or $0.24 per diluted share.
RxSight, Inc. reported third-quarter 2026 revenue of $24.6 million, down 19% from $30.3 million a year earlier, as lower product sales weighed on results. The company posted a net loss of $16.2 million, or $0.39 per diluted share, compared with a net loss of $9.8 million, or $0.24 per diluted share…